(Q40468173)

20 September 2017

1 reference

title

Medical use of psychostimulants: an overview. (English)

1 reference

20 September 2017

V F Holmes

1

1 reference

20 September 2017

publication date

1 January 1995

1 reference

International Journal of Psychiatry in Medicine

20 September 2017

published in

1 reference

20 September 2017

volume

25

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

1-19

1 reference

Psychologic and neuroendocrine response to methylphenidate

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Effects of amphetamine, methylphenidate, and apomorphine on regional brain serotonin and 5-hydroxyindole acetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

The use of psychostimulants in general psychiatry. A reconsideration

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Are too many children being treated with methylphenidate?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Postoperative effects of methylphenidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Effects of d-amphetamine and apomorphine in a new animal model of petit mal epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Methylphenidate Interaction With Both Anticonvulsants and Ethyl Biscoumacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Drug interactions: effect of methylphenidate on the disposition of diphenylhydantoin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Effect of methylphenidate on plasma anticonvulsant levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Prevention of stress-induced gastric ulcers by dopamine agonists in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Effects of acute and chronic methylphenidate administration on beta-endorphin, growth hormone, prolactin and cortisol in children with attention deficit disorder and hyperactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Improving senile behavior with reserpine and ritalin; new approach with use of methyl phenylpiperidylacetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Treatment of hypersomnolence in myotonic dystrophy with a CNS stimulant.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Enuresis: a new look at stimulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Beneficial effects of dextro-amphetamine in the treatment of vasodepressor syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Methylphenidate (Ritalin) treatment of cocaine dependence--a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Treatment of chronic cocaine abuse and attention deficit disorder, residual type, with magnesium pemoline.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

The effect of d-amphetamine and ephedrine on smoking attitude and behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Dexamethasone suppression test and mood response to methylphenidate in primary depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Amphetamine and tranylcypromine in treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Psychostimulants in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Treatment of imipramine-resistant depression and lithium-refractory mania through drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Alleviation of manic symptoms with catecholamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Mood responses of remitted schizophrenics to methylphenidate infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

D-amphetamine in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Biological challenges in obsessive compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Dextroamphetamine and dexamethasone suppression test prediction of desipramine response.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Side effects of corticosteroid therapy. Psychiatric aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Steroids may influence changes in mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Cerebral arteritis and oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Possible association of ischemic stroke with phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Pemoline and the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Methylphenidate-induced cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Methylphenidate, neuroleptics and dyskinesia-dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Methylphenidate-induced choreoathetosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

Stuttering and stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2F2TVT-2LH0-AD5A-CP91

10.2190/2TVT-2LH0-AD5A-CP91

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference